PCN4 ECONOMIC EVALUATION OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. OTHER IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES- A UK BUDGET IMPACT ANALYSIS
Abstract
Authors
M Botteman M Aapro JW Hay J Stephens J Brandman